Stillwater Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Stillwater Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,535	Closed	-$11.8M	–	73
2023 Q2	$11.8M	Buy	22,535 +118	+0.5%	+$63.7K	2.08%	21
2023 Q1	$12.9M	Sell	22,417 -136	-0.6%	-$76.7K	2.51%	16
2022 Q4	$12.4M	Sell	22,553 -177	-0.8%	-$93.8K	2.62%	17
2022 Q3	$11.5M	Sell	22,730 -1,592	-7%	-$891K	2.63%	14
2022 Q2	$13.2M	Buy	24,322 +1,112	+5%	+$612K	2.45%	17
2022 Q1	$13.7M	Sell	23,210 -1,144	-5%	-$657K	2.2%	21
2021 Q4	$16.3M	Sell	24,354 -201	-0.8%	-$125K	2.47%	17
2021 Q3	$14M	Buy	24,555 +24,132	+5,705%	+$13.2M	2.31%	19
2021 Q2	$213K	Buy	+423	New	+$200K	0.04%	72

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Stillwater Capital Advisors's TMO Position: Q3 2023 in Review

Stillwater Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 22,535 shares — an estimated $11.8M sold.

Stillwater Capital Advisors first reported a position in TMO in Q2 2021 and held it in 9 quarters. The position peaked at $16.3M in Q4 2021. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Stillwater Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Stillwater Capital Advisors sold 22,535 Thermo Fisher Scientific shares in Q3 2023, an estimated $11.8M.
Stillwater Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 9 quarters.
Stillwater Capital Advisors's Thermo Fisher Scientific position peaked at $16.3M in Q4 2021.
2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Stillwater Capital Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.